Literature Search

Pecorino(Basilio),Rubino(Cinzia),Guardalà(Vi… J Gynecol Oncol 0000-00-00

...MSH2, MSH6, PMS2) and microsatellite instability (MSI) test. For samples that resulted negative to IHC (abnormal finding...

García-Tello(A),Ramón de Fata(F),Andrés(G),R… Actas Urol Esp 0000-00-00

...MSH2 and hMSH6) in sections performed with tissue microarray (TMA) and their association with clinical-pathological para...

Yoo(Koo Han),Won(Kyu Yeoun),Lim(Sung-Jig),Pa… Oncol Lett 0000-00-00

...MSH2 expression status (MSH2-negative, n=53; MSH2-positive, n=76). T stage was significantly higher in the MSH2-negative...

Donadeu(F X),Mohammed(B T),Ioannidis(J) Domest Anim Endocrinol 0000-00-00

...MSH2 in either or both cell types during atresia. Based on increases in miRNA levels simultaneous with decreases in targ...

Chae(Y),Kim(J),Sohn(S),Moon(J),Kim(S),Ryoo(H… J Clin Oncol 0000-00-00

...MSH2, POLE, DNMT3, and XAB2) and 14 apoptosis-related genes (LTA [Lymphotoxin alpha], TP53, BCL2, BCL2L [BCL2 ligand], B...

Zaanan(A),Cuilliere-Dartigues(P),Parc(Y),Lou… J Clin Oncol 0000-00-00

...MSH2 or MSH6 expression and 97 tumors (51.1%) overexpressed p53 (p53). The addition of oxaliplatin to a regimen of FL si...

Palmieri(G),Colombino(M),Camboni(M G),Manca(… J Clin Oncol 0000-00-00

...MSH2) were included into the study. Genomics DNA was screened using DHPLC for FANC-C/G/E/F genes and using MPLA for FANC...

Gentile(A L),Pinto(C),Ceccarelli(C),Di Fabio… J Clin Oncol 0000-00-00

...MSH2 was performed in pretreatment biopsy and operative specimen.,Between March 2002 and May 2005, 32 pts had completed ...

Jenkins(M A),Baglietto(L),Dowty(J G),Vasen(H… J Clin Oncol 0000-00-00

...MSH2. Germline mutations in the mismatch repair gene MSH6 account for about 13% of colorectal cancer caused by mismatch ...

Olsson(H),Magnusson(S),Borg(Å),Nilberth(M),W… J Clin Oncol 0000-00-00

...MSH2 MSH6) (n=31) and CDKN2A (n=15) genes in comparison with population based control families (n=854). Family trees wer...